Search research articles
Contact Us
Filters
Showing results (71-80 of 129) with videos related to
Page
of 13
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial
C Sessa, G Bolis, N Colombo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 1997
Ovarian cancer risk and history of selected medical conditions linked with female hormones
F Parazzini, S Moroni, C La Vecchia, et al.
Gynecologic Oncology
|
November 1, 1990
The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy
G Bolis, F Zanaboni, P Vanoli, et al.
Gynecologic Oncology
|
November 1, 1988
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)
G Bolis, C Bonazzi, F Landoni, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study
G Bolis, G Bortolozzi, G Carinelli, et al.
European Journal of Cancer
|
January 1, 1979
Decreased half life of cyclophosphamide in patients under continual treatment
M D'Incalci, G Bolis, T Facchinetti, et al.
Gynecologic Oncology
|
July 1, 1999
Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival
F Parazzini, G Valsecchi, G Bolis, et al.
European Journal of Gynaecological Oncology
|
January 19, 2013
Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases only
E Grossi, S Noli, G Scarfone, et al.
Tumori
|
February 29, 1988
Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior
G Bolis, C Belloni, C Bonazzi, et al.
Tumori
|
June 30, 1987
Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor
G Bolis, N Colombo, A Epis, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 129) with videos related to
Sort By:
Page
of 13
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial
C Sessa, G Bolis, N Colombo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 1997
Ovarian cancer risk and history of selected medical conditions linked with female hormones
F Parazzini, S Moroni, C La Vecchia, et al.
Gynecologic Oncology
|
November 1, 1990
The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy
G Bolis, F Zanaboni, P Vanoli, et al.
Gynecologic Oncology
|
November 1, 1988
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)
G Bolis, C Bonazzi, F Landoni, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study
G Bolis, G Bortolozzi, G Carinelli, et al.
European Journal of Cancer
|
January 1, 1979
Decreased half life of cyclophosphamide in patients under continual treatment
M D'Incalci, G Bolis, T Facchinetti, et al.
Gynecologic Oncology
|
July 1, 1999
Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival
F Parazzini, G Valsecchi, G Bolis, et al.
European Journal of Gynaecological Oncology
|
January 19, 2013
Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases only
E Grossi, S Noli, G Scarfone, et al.
Tumori
|
February 29, 1988
Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior
G Bolis, C Belloni, C Bonazzi, et al.
Tumori
|
June 30, 1987
Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor
G Bolis, N Colombo, A Epis, et al.
Page
of 13